Which patents specifically cover bosulif's manufacturing process?

I don’t have enough information in the provided materials to identify which specific patents cover Bosulif’s (bosutinib) manufacturing process. If you share the patent list, patent numbers/publication IDs, or a source document (e.g., an FDA Orange Book entry, assignment database extract, or a patent landscaping report), I can map which ones specifically relate to manufacturing (process) versus formulation, composition of matter, or methods of treatment.

To narrow it quickly, please provide one of the following:
- The Orange Book entry text for Bosulif (including patent numbers), or
- A list of Bosulif-related patent numbers/publication IDs you have, or
- The jurisdiction you care about (US, EP, WO) and whether you mean “manufacturing process” (e.g., synthesis routes, crystallization, polymorph control, particle size, purification) or “manufacturing method” (GMP/scale-up steps).